[1] Numakawa
T, Odaka H, Adachi N. Actions of brain-derived neurotrophin factor in the
neurogenesis and neuronal function, and its involvement in the pathophysiology
of brain diseases[J]. Int J Mol Sci, 2018,19(11):3650. DOI:
10.3390/ijms19113650.
[2] Barde YA, Edgar D, Thoenen H.
Purification of a new neurotrophic factor from mammalian brain[J]. EMBO J,
1982, 1(5):549-553.
[3] Palasz E, Wysocka A, Gasiorowska A, et
al. BDNF as a promising therapeutic agent in parkinson's disease[J]. Int J Mol
Sci, 2020, 21(3):1170. DOI: 10.3390/ijms21031170.
[4] Pezet S, McMahon SB. Neurotrophins:
mediators and modulators of pain[J]. Annu Rev Neurosci, 2006, 29:507-538. DOI:
10.1146/annurev.neuro.29.051605. 112929.
[5] Liu W, Wang X, O'Connor M, et al.
Brain-derived neurotrophic factor and its potential therapeutic role in stroke
comorbidities[J]. Neural Plast, 2020, 2020:1969482. DOI: 10.1155/2020/1969482.
[6] Maaijwee NA, Rutten-Jacobs LC,
Schaapsmeerders P, et al. Ischaemic stroke in young adults: risk factors and
long-term consequences[J]. Nat Rev Neurol, 2014, 10(6):315-325. DOI:
10.1038/nrneurol.2014.72.
[7] Kaplan DR, Miller FD. Neurotrophin
signal transduction in the nervous system[J]. Curr Opin Neurobiol, 2000, 10(3):
381-391. DOI: 10.1016/s0959-4388(00)00092-1.
[8] Lima Giacobbo B, Doorduin J, Klein HC,
et al. Brain-derived neurotrophic factor in brain disorders: focus on
neuroinflammation[J]. Mol Neurobiol, 2019, 56(5): 3295-3312. DOI:
10.1007/s12035-018-1283-6.
[9] Dwivedi Y. Involvement of brain-derived
neurotrophic factor in late-life depression[J]. Am J Geriatr Psychiatry, 2013,
21(5): 433-449. DOI: 10.1016/j.jagp.2012.10.026.
[10] Begni V, Riva MA, Cattaneo A. Cellular and
molecular mechanisms of the brain-derived neurotrophic factor in physiological
and pathological conditions[J]. Clin Sci (Lond), 2017, 131(2): 123-138. DOI:
10.1042/CS20160009.
[11] Pruunsild P, Kazantseva A, Aid T, et al.
Dissecting the human BDNF locus: bidirectional transcription, complex splicing,
and multiple promoters[J]. Genomics, 2007, 90(3): 397-406. DOI:
10.1016/j.ygeno.2007.05.004.
[12] McGregor CE, English AW. The role of
BDNF in peripheral nerve regeneration: activity-dependent treatments and
Val66Met[J]. Front Cell Neurosci, 2019, 12: 522. DOI: 10.3389/fncel.2018.00522.
[13] Hempstead BL. Brain-derived neurotrophic
factor: three ligands, many actions[J]. Trans Am Clin Climatol Assoc, 2015,
126: 9-19.
[14] Goodman LJ, Valverde J, Lim F, et al.
Regulated release and polarized localization of brain-derived neurotrophic
factor in hippocampal neurons[J]. Mol Cell Neurosci, 1996, 7(3): 222-238. DOI:
10.1006/mcne.1996.0017.
[15] Sato Y, Chin Y, Kato T, et al. White
matter activated glial cells produce BDNF in a stroke model of monkeys[J].
Neurosci Res, 2009, 65(1): 71-78. DOI: 10.1016/j.neures. 2009.05.010.
[16] Notaras M, van den Buuse M.
Brain-derived neurotrophic factor (BDNF): novel insights into regulation and
genetic variation[J]. Neuroscientist, 2019, 25(5): 434-454. DOI:
10.1177/1073858418810142.
[17] Mou Z, Hyde TM, Lipska BK, et al. Human
obesity associated with an intronic snp in the brain-derived neurotrophic
factor locus[J]. Cell Rep, 2015, 13(6): 1073-1080. DOI:
10.1016/j.celrep.2015.09.065.
[18] Notaras M, Du X, Gogos J, et al. The
BDNF Val66Met polymorphism regulates glucocorticoid-induced corticohippocampal
remodeling and behavioral despair[J]. Transl Psychiatry, 2017, 7(9): e1233.
DOI: 10.1038/tp. 2017.205.
[19] Harrison RA, Field TS. Post stroke pain:
identification, assessment, and therapy[J]. Cerebrovasc Dis, 2015, 39(3-4):
190-1201. DOI: 10.1159/000375397.
[20] Langhorne P, Stott DJ, Robertson L, et
al. Medical complications after stroke: a multicenter study[J]. Stroke, 2000,
31(6): 1223-1229. DOI: 10.1161/01.str.31.6.1223.
[21] O'Donnell MJ, Diener HC, Sacco RL, et
al. Chronic pain syndromes after ischemic stroke: PRoFESS trial[J]. Stroke,
2013, 44(5): 1238-1243. DOI: 10.1161/STROKEAHA. 111.671008.
[22] Lundström E, Smits A, Terént A, et al.
Risk factors for stroke-related pain 1 year after first-ever stroke[J]. Eur J
Neurol, 2009, 16(2): 188-193. DOI: 10.1111/j.1468-1331. 2008.02378.x.
[23] Tang WK, Liang H, Mok V, et al. Is pain
associated with suicidality in stroke?[J] Arch Phys Med Rehabil, 2013, 94(5):
863-866. DOI: 10.1016/j.apmr.2012.11.044.
[24] Payton H, Soundy A. The experience of
post-stroke pain and the impact on quality of life: an integrative review[J].
Behav Sci (Basel), 2020, 10(8):128. DOI: 10.3390/bs10080128.
[25] Merighi A, Salio C, Ghirri A, et al.
BDNF as a pain modulator[J]. Prog Neurobiol, 2008, 85(3): 297-317. DOI:
10.1016/j.pneurobio.2008.04.004.
[26] Malfait AM, Miller RE, Block JA.
Targeting neurotrophic factors: novel approaches to musculoskeletal pain[J].
Pharmacol Ther, 2020, 211: 107553. DOI: 10.1016/j.pharmthera.2020.107553.
[27] Salio C, Ferrini F. BDNF and GDNF
expression in discrete populations of nociceptors[J]. Ann Anat, 2016, 207:
55-61. DOI: 10.1016/j.aanat.2015.12.001.
[28] Cappoli N, Tabolacci E, Aceto P, et al.
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain
perception[J]. J Neuroimmunol, 2020, 349: 577406. DOI:
10.1016/j.jneuroim.2020.577406.
[29] Nijs J, Meeus M, Versijpt J, et al.
Brain-derived neurotrophic factor as a driving force behind neuroplasticity in
neuropathic and central sensitization pain: a new therapeutic target?[J].
Expert Opin Ther Targets, 2015, 19(4): 565-576. DOI: 10.1517/14728222.
2014.994506.
[30] 李亚侃,鞠军亮. 脑卒中后抑郁患者炎症标志物的研究进展[J]. 医学综述,2021,27(12):2333-2337. DOI:10.3969/j.issn.1006-2084.2021.12.009.
[31] 刘喜艳,甄微,张钦聪,等. 脑卒中后抑郁治疗与预防[J]. 中国老年学杂志,2018,38(4):1010-1014.
DOI:10.3969/j.issn.1005-9202.2018.04.095.
[32] Hackett ML, Pickles K. Part I: frequency
of depression after stroke: an updated systematic review and meta-analysis of
observational studies[J]. Int J Stroke, 2014, 9(8): 1017-1025. DOI:
10.1111/ijs.12357.
[33] Bai YY, Ruan CS, Yang CR, et al. ProBDNF
signaling regulates depression-like behaviors in rodents under chronic
stress[J]. Neuropsychopharmacology, 2016, 41(12): 2882-2892. DOI:
10.1038/npp.2016.100.
[34] Yang B, Wang L, Nie Y, et al. proBDNF
expression induces apoptosis and inhibits synaptic regeneration by regulating
the RhoA-JNK pathway in an in vitro post-stroke depression model[J]. Transl
Psychiatry, 2021, 11(1):578. DOI: 10.1038/s41398-021-01667-2.
[35] Kang Z, Ye H, Chen T, et al. Effect of
electroacupuncture at siguan acupoints on expression of BDNF and TrkB proteins
in the hippocampus of post-stroke depression rats[J]. J Mol Neurosci, 2021,
71(10): 2165-2171. DOI: 10.1007/s12031-021-01844-4.
[36] Ren H, Han R, Liu X, et al.
Nrf2-BDNF-TrkB pathway contributes to cortical hemorrhage-induced depression,
but not sex differences[J]. J Cereb Blood Flow Metab, 2021, 41(12): 3288-3301.
DOI: 10.1177/0271678X211029060.
[37] Xu Y, Liang L. Vitamin D3/vitamin D
receptor signaling mitigates symptoms of post-stroke depression in mice by
upregulating hippocampal BDNF expression[J]. Neurosci Res, 2021, 170: 306-313.
DOI: 10.1016/j.neures.2020. 08.002.
|